Ejectdelay
FDA Label NDC 57483-003

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Innovus Pharmaceuticals, Inc. for the product Ejectdelay (NDC 57483-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, indications, warnings, when using this product, stop use and ask a doctor if, keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Benzocaine 7.5%

Purpose

Male genital desensitizer

Indications

Helps in the prevention of premature ejaculation

Warnings

For external use only

When Using This Product

Avoid contact with eyes

Stop Use And Ask A Doctor If

  • Premature ejaculation may be due to a condition requiring medical supervision
  • This product, used as directed, does not provide relief, discontinue use and consult a physician
  • You or your partner develop a rash or irritation, such as burning or itching, discontinue use
  • If symptoms persist, consult a doctor

Keep Out Of Reach Of Children

If swallowed, get medical help or contact a Poison Control Center right away

Directions

Apply a small amount to head and shaft of penis before intercourse, or use as directed by a physician.

Wash product off after intercourse

Inactive Ingredients

Glycerin Natural USP Kosher, PEG 8 Pluracol E 400 NF, PEG 3350, PEG 540 Blend USP, Carbowax 4000, Sodium Saccharin Powder USP, Sorbic Acid, Water

Questions Or Comments

For questions or comments please call 1-858-964-5123

Package Label.Principal Display Panel

Image Of Carton And Label (Carton)

Image Of Carton And Label (Carton)

* Please review the disclaimer below.